Tag Archives: patients

Patients who had more severe COVID-19 may be the best donors for convalescent plasma therapy

Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease, according to a new study co-led by researchers at Johns Hopkins Bloomberg School of Public Health. The findings suggest that older males who have recovered from COVID-19… Read More »

Drug May Extend A.L.S. Patients’ Lives by Several Months, Study Finds

A potential therapy for amyotrophic lateral sclerosis, a fatal neurological disorder, may allow patients to live several months longer than they otherwise would have, according to a study published Friday. The two-drug combination, dreamed up by two college students, is one of several potential treatments raising the hopes of patients with A.L.S., also known as… Read More »

Virtual follow-up care is more convenient and just as beneficial to surgical patients

Surgical patients who participate in virtual follow-up visits after their operations spend a similar amount of time with surgical team members as those who meet face-to-face. Moreover, these patients benefit by spending less time waiting at and traveling to the clinic for in-person appointments, according to research findings presented at the virtual American College of… Read More »

Half of Medicare patients do not receive recommended healthcare after hospitalization

In the period from October 2015 to September 2016, before the Affordable Care Act, a substantial portion of Medicare patients referred to home healthcare after hospitalization did not receive that care, new findings show. Using national data, the researchers detailed how often Medicare patients referred to home healthcare services after a hospital discharge received one… Read More »

FDA Approves Blenrep (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

FDA Approves Blenrep (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Print this page London UK 05 August 2020 — GlaxoSmithKline announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) as a monotherapy treatment for adult patients with relapsed or refractory multiple myeloma who have received… Read More »